← FDA DRUG APPROVALS

FDA NDA · NDA040024

DEXFERRUM

Sponsor: AM REGENT

APPLICATION
NDA040024
TYPE
NDA
ORIGINAL APPROVAL
1996-02-23
LATEST ACTION
2016-11-18
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

DEXFERRUMDiscontinued
IRON DEXTRAN EQ 50MG IRON/ML · INJECTABLE · INJECTION

Approval history

2016-11-18Manufacturing (CMC) · Supplement 25 · standardAP
2009-08-12Labeling · Supplement 22 · standardLabelAP
2002-02-08Labeling · Supplement 12 · standardAP
2001-05-31Manufacturing (CMC) · Supplement 11AP
2000-07-20Manufacturing (CMC) · Supplement 9AP
2000-07-20Manufacturing (CMC) · Supplement 8AP
2000-02-18Labeling · Supplement 10 · standardAP
1998-09-25Manufacturing (CMC) · Supplement 4AP
1998-09-25Labeling · Supplement 7 · standardAP
1998-09-25Manufacturing (CMC) · Supplement 5AP
1998-09-25Manufacturing (CMC) · Supplement 6AP
1998-01-29Labeling · Supplement 2 · standardAP
1998-01-29Labeling · Supplement 3 · standardAP
1996-09-19Manufacturing (CMC) · Supplement 1AP
1996-02-23UNKNOWN · Original · unknownAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →